>>Signaling Pathways>> GPCR/G protein>> Vasopressin Receptor>>RG7713 (RO5028442)

RG7713 (RO5028442) (Synonyms: RO5028442)

Catalog No.GC30890

RG7713(RO5028442)(RO5028442)은 Kis가 1nM(hV1a) 및 39nM(mV1a)인 매우 강력하고 선택적인 뇌 침투성 바소프레신 1a(V1a) 수용체 길항제입니다.

Products are for research use only. Not for human use. We do not sell to patients.

RG7713 (RO5028442) Chemical Structure

Cas No.: 920022-47-5

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$399.00
재고 있음
1mg
US$138.00
재고 있음
5mg
US$414.00
재고 있음
10mg
US$689.00
재고 있음
50mg
US$2,023.00
재고 있음
100mg
US$3,033.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

RG7713 (RO5028442) is a highly potent and selective Brain-Penetrant Vasopressin 1a (V1a) receptor antagonist with Kis of 1 nM (hV1a) and 39 nM (mV1a).

RG7713 (RO5028442) (compound 8) has excellent binding in and functional affinity for hV1a, moderate mouse affinity, and excellent selectivity versus human V2 (hV2) and human oxytocin (hOT) receptors. RG7713 (RO5028442) shows high solubility. RG7713 (RO5028442) is found to be highly selective against a panel of 89 targets. Finally, RG7713 (RO5028442) is identified as a suitable compound for clinical studies[1].

[1]. Ratni H, et al. Discovery of highly selective brain-penetrant vasopressin 1a antagonists for the potential treatment of autism via a chemogenomic and scaffold hopping approach. J Med Chem. 2015 Mar 12;58(5):2275-89.

리뷰

Review for RG7713 (RO5028442)

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for RG7713 (RO5028442)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.